How much is AZTherapies worth in 2026?

AZTherapies has a current valuation of N/A based on their Later Stage VC (Series C1) round and secondary market data.

How much funding has AZTherapies raised?

AZTherapies has raised N/A in total funding across 2 funding rounds.

AZTherapies

Drug Discovery

Current Valuation

N/A

As of September 29, 2020

Total Funding Raised

N/A

Across 2 rounds

Last Round

Later Stage VC (Series C1)

$33.6M

Last Funding

Sep 2020

Funding date

Capital Efficiency

N/A

Valuation / Funding

Interested in buying or selling AZTherapies shares?

Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 29, 2020	Later Stage VC (Series C1)	$33.6M	N/A	-
January 31, 2020	Later Stage VC (Series C)	$37.5M	N/A	-

Valuation Analysis

Current Valuation Metrics

AZTherapies is currently valued at N/A as of September 29, 2020.

Explore More Data

Detailed analysis for AZTherapies

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

See full funding history

What is AZTherapies Worth in 2026?

AZTherapies is a leading private company in the Drug Discovery sector. Track AZTherapies's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How AZTherapies Valuation is Determined

Private company valuations like AZTherapies's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.